906 related articles for article (PubMed ID: 3500183)
1. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
Ogushi F; Fells GA; Hubbard RC; Straus SD; Crystal RG
J Clin Invest; 1987 Nov; 80(5):1366-74. PubMed ID: 3500183
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase.
Ogushi F; Hubbard RC; Vogelmeier C; Fells GA; Crystal RG
J Clin Invest; 1991 Mar; 87(3):1060-5. PubMed ID: 1999486
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase.
Ogushi F; Hubbard RC; Fells GA; Casolaro MA; Curiel DT; Brantly ML; Crystal RG
Am Rev Respir Dis; 1988 Feb; 137(2):364-70. PubMed ID: 3257660
[TBL] [Abstract][Full Text] [Related]
4. Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.
Hubbard RC; McElvaney NG; Sellers SE; Healy JT; Czerski DB; Crystal RG
J Clin Invest; 1989 Oct; 84(4):1349-54. PubMed ID: 2794066
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.
Hubbard RC; Fells G; Gadek J; Pacholok S; Humes J; Crystal RG
J Clin Invest; 1991 Sep; 88(3):891-7. PubMed ID: 1653278
[TBL] [Abstract][Full Text] [Related]
6. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.
Hubbard RC; Ogushi F; Fells GA; Cantin AM; Jallat S; Courtney M; Crystal RG
J Clin Invest; 1987 Nov; 80(5):1289-95. PubMed ID: 2824559
[TBL] [Abstract][Full Text] [Related]
7. Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype null-null before and during alpha-1-antitrypsin augmentation therapy.
Wewers MD; Casolaro MA; Crystal RG
Am Rev Respir Dis; 1987 Mar; 135(3):539-43. PubMed ID: 3493719
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of recombinant DNA-directed E.coli produced alpha 1-antitrypsin as an anti-neutrophil elastase for potential use as replacement therapy of alpha 1-antitrypsin deficiency.
Straus SD; Fells GA; Wewers MD; Courtney M; Tessier LH; Tolstoshev P; Lecocq JP; Crystal RG
Biochem Biophys Res Commun; 1985 Aug; 130(3):1177-84. PubMed ID: 3896239
[TBL] [Abstract][Full Text] [Related]
9. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.
Nuijens JH; Abbink JJ; Wachtfogel YT; Colman RW; Eerenberg AJ; Dors D; Kamp AJ; Strack van Schijndel RJ; Thijs LG; Hack CE
J Lab Clin Med; 1992 Feb; 119(2):159-68. PubMed ID: 1740629
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterisation of the defective alpha 1-antitrypsin alleles PI Mwurzburg (Pro369Ser), Mheerlen (Pro369Leu), and Q0lisbon (Thr68Ile).
Poller W; Merklein F; Schneider-Rasp S; Haack A; Fechner H; Wang H; Anagnostopoulos I; Weidinger S
Eur J Hum Genet; 1999 Apr; 7(3):321-31. PubMed ID: 10234508
[TBL] [Abstract][Full Text] [Related]
11. Genetics of alpha 1-antitrypsin deficiency in relation to neonatal liver disease.
Povey S
Mol Biol Med; 1990 Apr; 7(2):161-72. PubMed ID: 2188061
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the sequence of the normal alpha-1-antitrypsin M3 allele and function of the M3 protein.
Curiel D; Laubach V; Vogelmeier C; Wurts L; Crystal RG
Am J Respir Cell Mol Biol; 1989 Dec; 1(6):471-7. PubMed ID: 2637759
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele.
Curiel DT; Vogelmeier C; Hubbard RC; Stier LE; Crystal RG
Mol Cell Biol; 1990 Jan; 10(1):47-56. PubMed ID: 1967187
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of "at risk" alpha 1-antitrypsin genotype SZ with synthetic oligonucleotide gene probes.
Nukiwa T; Brantly M; Garver R; Paul L; Courtney M; LeCocq JP; Crystal RG
J Clin Invest; 1986 Feb; 77(2):528-37. PubMed ID: 3484754
[TBL] [Abstract][Full Text] [Related]
15. Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits.
Silverman EK; Province MA; Campbell EJ; Pierce JA; Rao DC
Genet Epidemiol; 1992; 9(5):317-31. PubMed ID: 1427021
[TBL] [Abstract][Full Text] [Related]
16. Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin.
Curiel D; Brantly M; Curiel E; Stier L; Crystal RG
J Clin Invest; 1989 Apr; 83(4):1144-52. PubMed ID: 2539391
[TBL] [Abstract][Full Text] [Related]
17. Augmentation therapy of alpha 1-antitrypsin deficiency.
Hubbard RC; Crystal RG
Eur Respir J Suppl; 1990 Mar; 9():44s-52s. PubMed ID: 2340051
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency.
Blank CA; Brantly M
Ann Allergy; 1994 Feb; 72(2):105-20; quiz 120-2. PubMed ID: 8109800
[TBL] [Abstract][Full Text] [Related]
19. Elastase inhibitors of the respiratory tract.
Stockley RA; Morrison HM
Eur Respir J Suppl; 1990 Mar; 9():9s-15s. PubMed ID: 2340054
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the gene and protein of the alpha 1-antitrypsin "deficiency" allele Mprocida.
Takahashi H; Nukiwa T; Satoh K; Ogushi F; Brantly M; Fells G; Stier L; Courtney M; Crystal RG
J Biol Chem; 1988 Oct; 263(30):15528-34. PubMed ID: 3262617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
